Investor Relations
News Releases
Get News Alerts by Email
Corporate Governance
SEC Filings
Investor FAQs
Investor Contacts
Stock Information
Webcasts
Investors on Twitter

News Releases

 
Tecogen Sells Efficient Gas Chiller to New Medical Center Under Construction in New York City

WALTHAM, Mass., March 11, 2015 /PRNewswire/ -- Tecogen® Inc. (NASDAQ: TGEN) today announced the sale of a TECOCHILL® DTx 400 ton natural gas-powered chiller to a new outpatient medical center currently under construction in New York City.  The highly efficient chiller will provide reliable, cost-effective, chilled water for air conditioning the 15-story, approximately 200K square foot building.

The facility is pursuing LEED certification (Leadership in Energy and Environmental Design) and TECOCHILL's efficiency and low emissions will significantly contribute to the LEED certification point scoring system. In addition, the TECOCHILL unit features a heat-recovery option that turns 'waste heat' into hot water for domestic use.

"Being chosen to provide air conditioning for new construction of an outpatient medical center in NYC, proves once again, that Tecogen's reliable, cost-effective equipment is the right choice in large urban environments such as Manhattan," said Robert Panora, President and COO of Tecogen. 

TECOCHILL units eliminate the portion of the electricity usage associated with a facility's air-conditioning load and replace it with low-cost summer natural gas. Also, punitive charges relating to monthly peak demand are proportionately reduced.

About Tecogen
Tecogen manufactures, installs, and maintains high efficiency, ultra-clean combined heat and power products including natural gas engine-driven cogeneration, air conditioning systems, and high-efficiency water heaters for industrial and commercial use. Tecogen has an installed base of more than 2,000 units, supported by an established network of engineering, sales, and service personnel across the United States. For more information, please visit www.tecogen.com.

Tecogen Media Contact Information:
David Garrison
P: 781-466-6403
E: David.Garrison@Tecogen.com

Tecogen Investor Contact Information:
John N. Hatsopoulos
P: 781-622-1120
E: jhatsopoulos@tecogen.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tecogen-sells-efficient-gas-chiller-to-new-medical-center-under-construction-in-new-york-city-300048880.html

SOURCE Tecogen Inc.

Follow Tecogen_Inc on Twitter Follow Tecogen on LinkedIn Find us on Facebook